Description
Seeking men and women with Active Systemic Lupus Erythematosus (SLE) to undergo testing of CABA-201, an Autologous CD19-specific Chimeric Antigen Receptor T cells,
Overview
We are studying the effects of CABA-201 in individuals with active SLE to better understand how well this works (efficacy) and how safe and tolerable this treatment is.
What we're hoping for
To determine if treatment with CABA-201 is effective in participants with active SLE, as well as how well this works and how safe it is for these individuals.
Additional Information
ClinicalTrials.gov Identifier: NCT06121297